9GQhmrEXAAF1jLzNSS4HwYTKXLnAqp8vNabSE5k3iuDTHSeQ27tADFcp5isy

Comparison of Hepatotoxicity Associated with New BCR-ABL Tyrosine Kinase Inhibitors vs Imatinib Among Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis

Release Time:2022-03-01  Hits:

Indexed by: Journal Article

Date of Publication: 2021-12-15

Journal: JAMA Network Open

Volume: 4

Issue: 7

Page Number: 2120165-2120176

Prev One:Comparison of the drug-drug interactions potential of ibrutinib and acalabrutinib via inhibition of UDP-glucuronosyltransferase

Next One:In vitro inhibition of human UDP-glucuronosyltransferase (UGT) 1A1 by osimertinib, and prediction of in vivo drug-drug interactions